Ultreia Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Inactive
- Investments
-
30
- Exits
-
32

Ultreia Capital General Information
Company Description
Ultreia Capital was venture capital firm that used to specialize in the life science sectors.
Business Details
Website
www.ultreiacapital.comInvestor Status
Primary Investor Type
Corporate Office
- Schutzengasse 25
- P.O. Box 1310
- 8021 Zurich
- Switzerland
Ultreia Capital Investments (30)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Affinium Pharmaceuticals | 30-Aug-2013 | Later Stage VC | Pharmaceuticals | Out of Business | ||
SomaLogic Operating Company | 16-Nov-2010 | Biotechnology | Generating Revenue | |||
diaDexus | 08-Jun-2010 | Biotechnology | Generating Revenue/Not Profitable | |||
Zyomyx | 29-Jan-2010 | Diagnostic Equipment | Out of Business | |||
ESBATech | 07-Aug-2008 | Biotechnology | Generating Revenue | |||
Paratek Pharmaceuticals | 16-Apr-2008 | Pharmaceuticals | Generating Revenue/Not Profitable | |||
Genedata | 01-Mar-2007 | Other Healthcare Technology Systems | Generating Revenue | |||
Light Chain Bioscience | 30-Jun-2005 | Biotechnology | Generating Revenue | |||
Conforma Therapeutics | 01-Apr-2005 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 3 | ||
Predix Pharmaceuticals Holdings | 25-Jan-2005 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 |
Ultreia Capital Exits (32)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Genedata | 19-Aug-2024 | Merger/Acquisition | |
Light Chain Bioscience | 01-Jun-2021 | ||
Intarcia | 01-Nov-2020 | ||
LifeSpan BioSciences | 31-Aug-2018 | ||
Paratek Pharmaceuticals | 30-Oct-2014 | ||
Zyomyx | 01-Oct-2014 | ||
Affinium Pharmaceuticals | 11-Feb-2014 | ||
7TM Pharma | 01-Apr-2012 | ||
CEPTYR | 31-Mar-2012 | Bankruptcy: Liquidation | |
Anadys Pharmaceuticals | 23-Nov-2011 | Merger/Acquisition |
Ultreia Capital Investments by Industry, Year, and Region
Ultreia Capital FAQs
-
What is Ultreia Capital?
Ultreia Capital was venture capital firm that used to specialize in the life science sectors.
-
Where is Ultreia Capital headquartered?
Ultreia Capital is headquartered in Zurich, Switzerland.
-
How many investments has Ultreia Capital made?
Ultreia Capital has made 30 investments.
-
What has Ultreia Capital invested in?
Ultreia Capital has made numerous investments in companies like Affinium Pharmaceuticals, SomaLogic Operating Company, and diaDexus within the Pharmaceuticals and Biotechnology industries.
-
What has Ultreia Capital invested in recently?
Ultreia Capital's latest investment was on 30-Aug-2013 in Affinium Pharmaceuticals, a company within the Pharmaceuticals industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »